Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)

Meinolf Karthaus,Cso” szi Tibor,Vito Lorusso,Rajender Singh Arora,Alexander Filippov,Giada Rizzi,Maria Elisa Borroni,Giorgia Rossi,Steven M. Grunberg

Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)

2015

Meinolf Karthaus
Cso” szi Tibor
Vito Lorusso
Rajender Singh Arora
Alexander Filippov
Giada Rizzi
Maria Elisa Borroni
Giorgia Rossi
Steven M. Grunberg

Purpose This study aims to compare the efficacy and safety of oral palonosetron with intravenous (IV) palonosetron for the prevention of cisplatin-related chemotherapy-induced nausea and vomiting (CINV).

Keywords:

Palonosetron
Cisplatin
Dexamethasone
Vomiting
Nausea
Chemotherapy-induced nausea and vomiting
Chemotherapy
Anesthesia
Medicine
Oncology
highly emetogenic chemotherapy
Intensive care medicine
Internal medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations